兽用抗寄生虫药物新剂型及其新技术的研究进展

兽用抗寄生虫药物由于使用频繁,其给药技术研究一直备受重视.目前,兽用抗寄生虫药物新剂型和新技术的研究主要集中在缓释控释制剂和脂质体制剂,其次是透皮给药系统、微囊、微球、环糊精包合物、固体分散体等.但这些新剂型和新技术大多还处于研究阶段,在处方设计或制剂工艺方面都还存在一些问题,今后应加强这些新剂型的工艺和技术研究,以真正发挥这些新剂型的优点.     

鸡抗球虫药的体外筛选综述

抗鸡球虫药的筛选分为体内筛选和体外筛选。体外筛选具有简易、迅速、准确和经济的优点。本文在前人大量工作的基础上，总结了体外筛选的全过程，并分述了细胞培养筛选法和鸡胚培养筛选法。     

畜产品中兽药残留原因及危害

在畜禽饲养管理过程中使用违禁药物或滥用药物,使用饲料添加剂或超量用药,不遵守休药期规定等均可引起畜产品兽药残留。同时饲养环境遭到污染也能致使药物残留,并且我国关于食品安全的法律法规不健全、监管力度不够等,致使畜产品中药物残留问题更加严重。人体摄入存在药物残留的食品后,不仅会引起急性、慢性或蓄积性中毒,还会致使机体细菌产生耐药性,甚至污染整个生活环境等。     

Research Progress on Action Mechanism of Animal Anti-parasitical Drugs

Animal anti-parasitical drugs are mainly used to prevent and control animal parasitosis, and also an effective way to protect the healthy development of animal husbandry and public health security.The efficacy of anti-parasitical drugs depends on the interaction between drug molecular and different target tissues and target cells of parasite or animal.Because of the variety of anti-parasitical drugs, the anti-parasitical mechanisms are complex.With the development of new anti-parasitical drugs and the depth of scientific research, especially the development of chemical synthesis and biological pharmaceutical technology, the variety and quantity of anti-parasitical drugs constantly increase.With the discovery of new drug structure and its action target, the study on the mechanism is constantly deep.The author mainly summarized the research progress on action mechanism of anti-parasitical drugs.     

Cyclooxygenase (COX) inhibitors and the intestine

Nonsteroidal anti-inflammatory drugs (NSAIDs) have long been used for the treatment of pain and inflammation because of their inhibitory effects on cyclooxygenase (COX). For almost as long as NSAIDs have been in use, multiple adverse effects have been noted. Assessment of many of these adverse effects have been complicated because of the discovery of multiple splice variants of the cox gene, and a greater array of COX inhibitors, especially the COX-2 selective inhibitors have become available. Some of these adverse effects cannot be readily explained by the effect of these drugs on COX. This has sparked a new field of investigation into the COX-independent effects of the COX inhibitors. The major noncyclooxygenase targets of the COX inhibitors of particular relevance to inflammation and the gastrointestinal tract are phosphatidylinositol 3'-kinase Akt signaling, uncoupling of oxidative phosphorylation, PPARgamma, nuclear factor KB, mitogen activated protein kinases, and heat shock proteins.     

Target and non-target site mechanisms of fungicide resistance and their implications for the management of crop pathogens

Fungicides are indispensable for high-quality crops, but the rapid emergence and evolution of fungicide resistance have become the most important issues in modern agriculture. Hence, the sustainability and profitability of agricultural production have been challenged due to the limited number of fungicide chemical classes. Resistance to site-specific fungicides has principally been linked to target and non-target site mechanisms. These mechanisms change the structure or expression level, affecting fungicide efficacy and resulting in different and varying resistance levels. This review provides background information about fungicide resistance mechanisms and their implications for developing anti-resistance strategies in plant pathogens. Here, our purpose was to review changes at the target and non-target sites of quinone outside inhibitor (QoI) fungicides, methyl-benzimidazole carbamate (MBC) fungicides, demethylation inhibitor (DMI) fungicides, and succinate dehydrogenase inhibitor (SDHI) fungicides and to evaluate if they may also be associated with a fitness cost on crop pathogen populations. The current knowledge suggests that understanding fungicide resistance mechanisms can facilitate resistance monitoring and assist in developing anti-resistance strategies and new fungicide molecules to help solve this issue. © 2023 Society of Chemical Industry.     

不同驱虫药驱虫后伊犁马血液生化指标变化的研究

[目的] 研究不同驱虫药对伊犁马血液生化指标的影响,为伊犁马科学驱虫及健康养殖提供参考。[方法] 将平均体重（265.5±35.6）kg、出生日期相近的40匹1岁伊犁马随机分为5组,每组8匹,分别为对照组、试验Ⅰ组、试验Ⅱ组、试验Ⅲ组和试验Ⅳ组。在相同的饲养管理和日粮营养水平条件下,对照组不驱虫,在试验开始第1天,试验Ⅰ组使用伊维菌素驱虫,试验Ⅱ组使用吡喹酮驱虫,试验Ⅲ组使用阿苯达唑驱虫,试验Ⅳ组使用伊维菌素和阿苯达唑的混合药剂驱虫;在试验第14天采集马匹血液样品,测定血浆氮代谢指标、葡萄糖及酶相关指标、脂代谢指标及金属离子指标。[结果] ①试验Ⅲ组总蛋白（TP）浓度最低,与对照组、试验Ⅰ组、试验Ⅱ组及试验Ⅳ组相比,分别降低了8.16%、7.15%、4.98%及6.62%（P>0.05）。对照组及各试验组白蛋白（ALB）、尿素（UREA）浓度均无显著（P>0.05）差异。与对照组相比,试验Ⅲ组及试验Ⅳ组血浆中UREA浓度分别降低了33.15%及36.10%（P>0.05）。②与对照组相比,试验Ⅰ组、试验Ⅱ组、试验Ⅲ组、试验Ⅳ组丙氨酸氨基转移酶（ALT）活力分别降低了26.51%、21.11%、47.14%及52.38%（P>0.05）。试验Ⅲ组血浆中碱性磷酸酶（ALP）活力低于对照组,降低了0.19%（P>0.05）。与对照组相比,试验Ⅱ组和试验Ⅳ组的乳酸脱氢酶（LDH）活力显著（P<0.05）升高,分别提高了17.84%、13.51%;谷草转氨酶（AST）活力分别提高了5.40%和4.08%（P>0.05）。③对照组血浆中甘油三酯（TG）、肌酐（CREA）及尿酸（UA）的含量与各试验组相比均无显著（P>0.05）差异。试验Ⅰ组及试验Ⅳ组血浆中CREA浓度较对照组分别提高13.38%和9.86%（P>0.05）。试验Ⅱ组血浆中胆碱酯酶（CHE）活力显著（P<0.05）高于试验Ⅲ组,提高了17.70%。④对照组血浆中Mg²⁺浓度与各试验组相比差异不显著（P>0.05）;试验Ⅲ组血浆中Ca²⁺浓度最低,与对照组、试验Ⅰ组、试验Ⅱ组及试验Ⅳ组相比,分别降低了23.44%、16.40%、25.89%及21.43%（P<0.05）。[结论] 综合来看,使用伊维菌素和阿苯达唑混合驱虫,对伊犁马血浆中的氮代谢、糖脂代谢指标及肝功能代谢酶活力改善效果更明显。     

中兽药前处理及提取车间布局设计的分析与建议

中兽药是兽医用药的重要组成部分,兽用中药制剂的质量与中药材前处理及中药提取工艺密切相关。文章从车间布局、设施设备和车间环境要求等方面详细分析了《兽药生产质量管理规范》对中药前处理车间和中药提取车间的要求,并结合生产实际提出中药前处理车间和中药提取车间的设计建议,给兽药企业中药前处理车间和提取车间GMP改造提供参考,以期在设计和建造中降低企业成本,满足兽用中药提取物及中药制剂达到安全、有效、稳定、可控的质量要求。     

不同药物及给药途径对仔猪白痢治疗效果的影响

选择自然感染大肠杆菌、拉白色或灰白色稀粪的哺乳仔猪(要求无弱仔和其他疾病)195头为试验动物,以每窝仔猪为单位,随机分成两大组(每组设5个试验组),给药途径选用肌肉注射和后海穴注射药物;观测三九克痢注射液、氟哌酸注射液、恩诺沙星注射液、痢菌净、链霉素等5种药物对仔猪白痢治疗效果的影响。结果表明,肌注的5个实验组即Ⅰ、Ⅱ、Ⅲ、Ⅳ、Ⅴ组总有效率分别是75.0%、72.7%、58.8%、68.4%和52.9%(P﹤0.05),穴注的五个实验组即Ⅰ、Ⅱ、Ⅲ、Ⅳ、Ⅴ组总有效率分别是77.3%、72.0%、66.7%、73.7%和62.5%(P﹤0.05);肌注组的总有效率66.3%、穴注组的总有效率71.0%。结果表明,三九克痢的疗效与安全性都是最好的;其次是恩诺沙星;后海穴注射药物的疗效更好。